Morphology of susceptibility vessel sign predicts middle cerebral artery recanalization after intravenous thrombolysis

Stroke

Volumn 45, Issue 9, 2014, Pages 2795-2797

  Yan, Shenqiang ^a   Hu, Haitao ^a   Shi, Zhenghao ^a   Zhang, Xuting ^a   Zhang, Sheng ^b   Liebeskind, David S ^c   Lou, Min ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

magnetic resonance imaging; middle cerebral artery; stroke; thrombolytic therapy

Indexed keywords

AGED; ANATOMY AND HISTOLOGY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; AGED; FEMALE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84906821956     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.006144     Document Type: Article

References (12)

1. Sakamoto Y, Kimura K, Sakai K. M1 susceptibility vessel sign and hyperdense middle cerebral artery sign in hyperacute stroke patients. Eur Neurol. 2012;68:93-97.
2. Liebeskind DS, Sanossian N, Yong WH, Starkman S, Tsang MP, Moya AL, et al. CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke. 2011;42:1237-1243.
3. Jang IK, Gold HK, Ziskind AA, Fallon JT, Holt RE, Leinbach RC, et al. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis. Circulation. 1989;79:920-928.
4. Rovira A, Orellana P, Alvarez-Sabín J, Arenillas JF, Aymerich X, Grivé E, et al. Hyperacute ischemic stroke: middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging. Radiology. 2004;232:466-473.
5. Zhu L, Liebeskind DS, Jahan R, Starkman S, Salamon N, Duckwiler G, et al. Thrombus branching and vessel curvature are important determinants of middle cerebral artery trunk recanalization with Merci thrombectomy devices. Stroke. 2012;43:787-792.
6. Zaidat OO, Yoo AJ, Khatri P, Tomsick TA, von Kummer R, Saver JL, et al; Cerebral Angiographic Revascularization Grading (CARG) Collaborators; STIR Revascularization working group; STIR Thrombolysis in Cerebral Infarction (TICI) Task Force. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 2013;44:2650-2663.
7. Cho KH, Kim JS, Kwon SU, Cho AH, Kang DW. Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke. 2005;36:2379-2383.
8. Schellinger PD, Chalela JA, Kang DW, Latour LL, Warach S, Diagnostic and prognostic value of early MR Imaging vessel signs in hyperacute stroke patients imaged 3 hours and treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol. 2005;26:618-624
9. Kimura K, Sakamoto Y, Aoki J, Iguchi Y, Shibazaki K, Inoue T. Clinical and MRI predictors of no early recanalization within 1 hour after tissuetype plasminogen activator administration. Stroke. 2011;42:3150-3155.
10. Riedel CH, Zimmermann P, Jensen-Kondering U, Stingele R, Deuschl G, Jansen O. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke. 2011;42:1775-1777.
11. Shobha N, Bal S, Boyko M, Kroshus E, Menon BK, Bhatia R, et al. Measurement of length of hyperdense MCA sign in acute ischemic stroke predicts disappearance after IV tPA. J Neuroimaging. 2014;24:7-10.
12. Rohan V, Baxa J, Tupy R, Cerna L, Sevcik P, Friesl M, et al. Length of occlusion predicts recanalization and outcome after intravenous thrombolysis in middle cerebral artery stroke. Stroke. 2014;45: 2010-2017. doi:10.1161/ STROKEAHA.114.005731.